digoxigenin has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias-Carrión, O; Depboylu, C; Höglinger, GU; Oertel, WH; Schäfer, MK; Weihe, E | 1 |
| Arai, M; Cohen, JA; Hill, WD; Trojanowski, JQ | 1 |
2 other study(ies) available for digoxigenin and Parkinson Disease
| Article | Year |
|---|---|
Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease.
Topics: Aged; Autopsy; Complement C1q; Digoxigenin; Extracellular Space; Female; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Immunity, Innate; Immunohistochemistry; In Situ Hybridization; Male; Melanins; Parkinson Disease; Phagocytosis; Substantia Nigra; Tissue Fixation; Up-Regulation; Uridine Triphosphate | 2011 |
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Topics: Adult; Aged; Aged, 80 and over; Aging; Animals; Digoxigenin; Female; Histocytochemistry; Humans; Image Processing, Computer-Assisted; In Situ Hybridization; Lewy Bodies; Male; Melanins; Mice; Middle Aged; Neurofilament Proteins; Neurons; Parkinson Disease; RNA, Messenger; Substantia Nigra; Uridine Triphosphate | 1993 |